Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Select neurocognitive impairment in HIV-infected women: associations with HIV viral load, hepatitis C virus, and depression, but not leukocyte telomere length.

Giesbrecht CJ, Thornton AE, Hall-Patch C, Maan EJ, Côté HC, Money DM, Murray M, Pick N.

PLoS One. 2014 Mar 4;9(3):e89556. doi: 10.1371/journal.pone.0089556. eCollection 2014.

2.

Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women.

Wojna V, Robles L, Skolasky RL, Mayo R, Selnes O, de la Torre T, Maldonado E, Nath A, Meléndez LM, Lasalde-Dominicci J.

J Neurovirol. 2007 Dec;13(6):561-8.

3.

Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria.

Akolo C, Royal W 3rd, Cherner M, Okwuasaba K, Eyzaguirre L, Adebiyi R, Umlauf A, Hendrix T, Johnson J, Abimiku A, Blattner WA.

J Neurovirol. 2014 Aug;20(4):380-7. doi: 10.1007/s13365-014-0254-6. Epub 2014 Jun 14.

4.

Association between short leukocyte telomere length and HIV infection in a cohort study: No evidence of a relationship with antiretroviral therapy.

Zanet DL, Thorne A, Singer J, Maan EJ, Sattha B, Le Campion A, Soudeyns H, Pick N, Murray M, Money DM, Côté HC; CIHR Emerging Team Grant on HIV Therapy and Aging: CARMA.

Clin Infect Dis. 2014 May;58(9):1322-32. doi: 10.1093/cid/ciu051. Epub 2014 Jan 22.

PMID:
24457340
5.

Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people.

Clifford DB, Vaida F, Kao YT, Franklin DR, Letendre SL, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Grant I, Heaton RK; CHARTER Group.

Neurology. 2015 Jan 20;84(3):241-50. doi: 10.1212/WNL.0000000000001156. Epub 2014 Dec 10.

6.

Differential cognitive impairment in HCV coinfected men with controlled HIV compared to HCV monoinfection.

Sun B, Abadjian L, Rempel H, Monto A, Pulliam L.

J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):190-6. doi: 10.1097/QAI.0b013e31827b61f1.

7.

Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria.

Royal W 3rd, Cherner M, Carr J, Habib AG, Akomolafe A, Abimiku A, Charurat M, Farley J, Oluyemisi A, Mamadu I, Johnson J, Ellis R, McCutchan JA, Grant I, Blattner WA.

J Neurovirol. 2012 Jun;18(3):191-9. doi: 10.1007/s13365-012-0097-y. Epub 2012 Apr 18. Erratum in: J Neurovirol. 2012 Oct;18(5):441. McCutchen, J Allen [corrected to McCutchan, J Allen].

8.

Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria.

Royal W 3rd, Cherner M, Burdo TH, Umlauf A, Letendre SL, Jumare J, Abimiku A, Alabi P, Alkali N, Bwala S, Okwuasaba K, Eyzaguirre LM, Akolo C, Guo M, Williams KC, Blattner WA.

PLoS One. 2016 Feb 1;11(2):e0147182. doi: 10.1371/journal.pone.0147182. eCollection 2016.

9.

Depressive symptoms and neurocognitive performance among HIV-infected women.

Fialho RM, Pereira M, Mendonça N, Ouakinin S.

Women Health. 2013;53(2):117-34. doi: 10.1080/03630242.2013.767301.

PMID:
23517511
10.

Shorter telomere length - A potential susceptibility factor for HIV-associated neurocognitive impairments in South African women [corrected].

Malan-Müller S, Hemmings SM, Spies G, Kidd M, Fennema-Notestine C, Seedat S.

PLoS One. 2013;8(3):e58351. doi: 10.1371/journal.pone.0058351. Epub 2013 Mar 5. Erratum in: PLoS One. 2013;8(4). doi:10.1371/annotation/53ec3c1c-3247-452d-85c7-576fb35bdbe3.

11.

Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort.

Moore DJ, Roediger MJ, Eberly LE, Blackstone K, Hale B, Weintrob A, Ganesan A, Agan BK, Letendre SL, Crum-Cianflone NF.

PLoS One. 2012;7(11):e47310. doi: 10.1371/journal.pone.0047310. Epub 2012 Nov 8.

12.

Depression and neurocognitive performance in Portuguese patients infected with HIV.

Bragança M, Palha A.

AIDS Behav. 2011 Nov;15(8):1879-87. doi: 10.1007/s10461-011-9973-3.

PMID:
21598031
13.

The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease.

Letendre SL, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, Marcotte T, Heaton RK, McCutchan JA, Grant I; HNRC Group.

AIDS. 2005 Oct;19 Suppl 3:S72-8.

PMID:
16251831
14.

Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy-treated subjects with human immunodeficiency virus type 1 infection.

Sun B, Abadjian L, Rempel H, Calosing C, Rothlind J, Pulliam L.

J Neurovirol. 2010 Mar;16(2):115-24. doi: 10.3109/13550280903559789.

PMID:
20307252
15.

Neurocognitive functioning in acute or early HIV infection.

Moore DJ, Letendre SL, Morris S, Umlauf A, Deutsch R, Smith DM, Little S, Rooney A, Franklin DR, Gouaux B, Leblanc S, Rosario D, Fennema-Notestine C, Heaton RK, Ellis RJ, Atkinson JH, Grant I; CHARTER Group.

J Neurovirol. 2011 Feb;17(1):50-7. doi: 10.1007/s13365-010-0009-y. Epub 2010 Dec 15.

16.

Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.

Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha MJ, Hoy J, Miller C, Penalva de Oliveira AC, Pumpradit W, Shlay JC, El-Sadr W, Price RW; INSIGHT SMART Study Group.

Neurology. 2010 Sep 7;75(10):864-73. doi: 10.1212/WNL.0b013e3181f11bd8. Epub 2010 Aug 11.

17.

Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil.

de Almeida SM, Ribeiro CE, de Pereira AP, Badiee J, Cherner M, Smith D, Maich I, Raboni SM, Rotta I, Barbosa FJ, Heaton RK, Umlauf A, Ellis RJ.

J Neurovirol. 2013 Dec;19(6):550-6. doi: 10.1007/s13365-013-0215-5. Epub 2013 Nov 26.

18.

Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings.

Cherner M, Ellis RJ, Lazzaretto D, Young C, Mindt MR, Atkinson JH, Grant I, Heaton RK; HIV Neurobehavioral Research Center Group.

AIDS. 2004 Jan 1;18 Suppl 1:S27-34.

PMID:
15075495
19.

Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment.

Tozzi V, Balestra P, Galgani S, Narciso P, Ferri F, Sebastiani G, D'Amato C, Affricano C, Pigorini F, Pau FM, De Felici A, Benedetto A.

AIDS. 1999 Oct 1;13(14):1889-97.

PMID:
10513647
20.

Endocrine abnormalities in HIV-infected women are associated with peak viral load - the Children and Women: AntiRetrovirals and Markers of Aging (CARMA) Cohort.

Sokalski KM, Chu J, Mai AY, Qiu AQ, Albert AY, Zanet DL, Côté HC, Maan EJ, Pick N, Prior JC, Money DM, Murray MC; CIHR team grant on HIV therapy and aging: CARMA.

Clin Endocrinol (Oxf). 2016 Mar;84(3):452-62. doi: 10.1111/cen.12881. Epub 2015 Oct 20.

PMID:
26300027

Supplemental Content

Support Center